Here is the 5th Most Popular Stock Among Hedge Funds

In This Article:

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31st. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards Visa Inc (NYSE:V). We will also compare Visa against similarly valued stocks like Johnson & Johnson (NYSE:JNJ), JPMorgan Chase & Co. (NYSE:JPM), Mastercard Incorporated (NYSE:MA), and The Walt Disney Company (NYSE:DIS).

Is V stock a buy or sell? Visa Inc (NYSE:V) has seen an increase in hedge fund sentiment in recent months. Visa Inc (NYSE:V) was in 166 hedge funds' portfolios at the end of the fourth quarter of 2020. The all time high for this statistic was previously 160. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. There were 160 hedge funds in our database with V holdings at the end of September. Our calculations also showed that V ranked 5th among the 30 most popular stocks among hedge funds (click for Q4 rankings).

Hedge funds' reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn't keep up with the unhedged returns of the market indices. Our research was able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by more than 124 percentage points since March 2017 (see the details here).

Best Value Stocks To Buy Now
Best Value Stocks To Buy Now

Warren Buffett of Berkshire Hathaway

At Insider Monkey we leave no stone unturned when looking for the next great investment idea. Recently Oregon became the first state to legalize psychedelic mushrooms which are shown to have promising results in treating depression, addiction, and PTSD in early stage academic studies. So, we are checking out this psychedelic drug stock idea right now. We go through lists like the 10 best biotech stocks to invest in to pick the next stock that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage (or at the end of this article). Now we're going to view the fresh hedge fund action encompassing Visa Inc (NYSE:V).